4//SEC Filing
Cross John Harry III 4
Accession 0001854270-25-000026
CIK 0001854270other
Filed
Mar 10, 8:00 PM ET
Accepted
Mar 11, 4:14 PM ET
Size
5.7 KB
Accession
0001854270-25-000026
Insider Transaction Report
Form 4
Cross John Harry III
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-03-07+174,200→ 174,200 totalExercise: $3.52Exp: 2035-03-06→ Common Stock (174,200 underlying)
Footnotes (1)
- [F1]25% of the shares underlying this option vest on March 3, 2026 and the remainder vest in 36 substantially equal monthly installments thereafter, subject to the reporting person's continued service through the applicable vesting date.
Documents
Issuer
Senti Biosciences, Inc.
CIK 0001854270
Entity typeother
Related Parties
1- filerCIK 0001806763
Filing Metadata
- Form type
- 4
- Filed
- Mar 10, 8:00 PM ET
- Accepted
- Mar 11, 4:14 PM ET
- Size
- 5.7 KB